Pacific Biosciences of California  

(Public, NASDAQ:PACB)   Watch this stock  
Find more results for PACB
2.80
-0.09 (-3.11%)
Jun 18 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.71 - 2.94
52 week 1.06 - 3.25
Open 2.94
Vol / Avg. 487,055.00/437,089.00
Mkt cap 157.28M
P/E     -
Div/yield     -
EPS -1.56
Shares 56.17M
Beta     -
Inst. own 64%
Apr 29, 2013
Q1 2013 Pacific Biosciences Of California Inc Earnings Release
Apr 23, 2013
Q1 2013 Pacific Biosciences Of California Inc Earnings Conference Call
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin -378.34% -363.56%
Operating margin -369.43% -363.08%
EBITD margin - -337.49%
Return on average assets -62.83% -54.29%
Return on average equity -78.21% -62.80%
Employees 342 -
Carbon Disclosure Rating - -

Address

1380 Willow Rd.
MENLO PARK, CA 94025
United States - Map
+1-650-5218000 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Pacific Biosciences, Inc. develops Deoxyribonucleic Acid (DNA) sequencing platform. The Company designs and develops a method for single-molecule DNA sequencing that was developed through collaboration between the research groups of Harold Craighead and Watt Webb at Cornell University, United States. The Company's single molecule real time (SMRT) technology's combination of performance characteristics is the result of an approach that uses a single DNA polymerase working in a continuous processing manner to synthesize DNA.

Officers and directors

Michael W. Hunkapiller Ph.D. Executive Chairman of the Board, President, Chief Executive Officer
Age: 63
Bio & Compensation  - Reuters
Susan K. Barnes Chief Financial Officer, Executive Vice President
Age: 58
Bio & Compensation  - Reuters
Kevin Corcoran Senior Vice President
Age: 53
Bio & Compensation  - Reuters
Michael Phillips Senior Vice President - Research and Development
Age: 61
Bio & Compensation  - Reuters
Jonas Korlach Ph.D. Chief Scientific Officer
Bio & Compensation  - Reuters
William Ericson Lead Independent Director
Age: 53
Bio & Compensation  - Reuters
David Botstein Ph.D. Director
Age: 69
Bio & Compensation  - Reuters
Anthony B. Evnin Ph.D. Director
Age: 71
Bio & Compensation  - Reuters
Lucy Shapiro PhD Director
Age: 72
Bio & Compensation  - Reuters
Brook H. Byers Ph.D, MBA Independent Director
Age: 66
Bio & Compensation  - Reuters